These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7731703)

  • 61. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene.
    Feng Z; Hu W; Rom WN; Beland FA; Tang MS
    Carcinogenesis; 2002 Oct; 23(10):1721-7. PubMed ID: 12376482
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytosine methylation determines hot spots of DNA damage in the human P53 gene.
    Denissenko MF; Chen JX; Tang MS; Pfeifer GP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3893-8. PubMed ID: 9108075
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).
    Mancini D; Singh S; Ainsworth P; Rodenhiser D
    Am J Hum Genet; 1997 Jul; 61(1):80-7. PubMed ID: 9245987
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutation and methylation status of p53 gene promoter in human breast tumours.
    Nayak BK; Das BR
    Tumour Biol; 1999; 20(6):341-6. PubMed ID: 10567880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutagenesis at methylated CpG sequences.
    Pfeifer GP
    Curr Top Microbiol Immunol; 2006; 301():259-81. PubMed ID: 16570852
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Strand bias in mutation involving 5-methylcytosine deamination in the human hprt gene.
    Skandalis A; Ford BN; Glickman BW
    Mutat Res; 1994 Jan; 314(1):21-6. PubMed ID: 7504188
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: the site of the recurrent substitution mutation in exon 31.
    Andrews JD; Mancini DN; Singh SM; Rodenhiser DI
    Hum Mol Genet; 1996 Apr; 5(4):503-7. PubMed ID: 8845843
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro aflatoxin B1-induced p53 mutations.
    Chan KT; Hsieh DP; Lung ML
    Cancer Lett; 2003 Sep; 199(1):1-7. PubMed ID: 12963117
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extent of CpG methylation is not proportional to the in vivo spontaneous mutation frequency at transgenic loci in Big Blue rodents.
    Monroe JJ; Manjanatha MG; Skopek TR
    Mutat Res; 2001 May; 476(1-2):1-11. PubMed ID: 11336978
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide.
    Murata J; Tada M; Iggo RD; Sawamura Y; Shinohe Y; Abe H
    Mutat Res; 1997 Oct; 379(2):211-8. PubMed ID: 9357550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes.
    Rideout WM; Coetzee GA; Olumi AF; Jones PA
    Science; 1990 Sep; 249(4974):1288-90. PubMed ID: 1697983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutational spectra of human cancer.
    Pfeifer GP; Besaratinia A
    Hum Genet; 2009 Jun; 125(5-6):493-506. PubMed ID: 19308457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants.
    Flatau E; Bogenmann E; Jones PA
    Cancer Res; 1983 Oct; 43(10):4901-5. PubMed ID: 6883340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG-->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells.
    Lee DH; O'Connor TR; Pfeifer GP
    Nucleic Acids Res; 2002 Aug; 30(16):3566-73. PubMed ID: 12177298
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequence specificity in CpG mutation hotspots.
    Ollila J; Lappalainen I; Vihinen M
    FEBS Lett; 1996 Nov; 396(2-3):119-22. PubMed ID: 8914970
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy.
    Shiao YH; Palli D; Buzard GS; Caporaso NE; Amorosi A; Saieva C; Fraumeni JF; Anderson LM; Rice JM
    Carcinogenesis; 1998 Dec; 19(12):2145-9. PubMed ID: 9886570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CpG deamination creates transcription factor-binding sites with high efficiency.
    Zemojtel T; Kielbasa SM; Arndt PF; Behrens S; Bourque G; Vingron M
    Genome Biol Evol; 2011; 3():1304-11. PubMed ID: 22016335
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides.
    Cooper DN; Mort M; Stenson PD; Ball EV; Chuzhanova NA
    Hum Genomics; 2010 Aug; 4(6):406-10. PubMed ID: 20846930
    [TBL] [Abstract][Full Text] [Related]  

  • 79. P53 mutations in thyroid carcinoma: tidings from an old foe.
    Farid NR
    J Endocrinol Invest; 2001; 24(7):536-45. PubMed ID: 11508790
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice.
    Epstein RJ; Lin FPY; Brink RA; Blackburn J
    PLoS One; 2023; 18(4):e0284327. PubMed ID: 37053216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.